Ry, Denmark

Carsten Thordal

This inventor holds 1 USPTO granted patent. Top assignee: Pharma-Vinci A/s. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carsten Thordal. Retrieved from https://idiyas.com/inventor/carsten-thordal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carsten Thordal: Innovator in Pharmaceutical Preparations

Introduction

Carsten Thordal is a notable inventor based in Ry, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of penicillin for rectal administration. His innovative approach has the potential to enhance the effectiveness of antibiotic treatments.

Latest Patents

Carsten Thordal holds a patent for a "Penicillin preparation for rectal administration." This preparation contains benzylpenicillin and sodium lauryl sulphate in a hard gelatin capsule. This invention represents a novel method of delivering penicillin, which could improve patient compliance and therapeutic outcomes.

Career Highlights

Thordal is associated with Pharma-Vinci A/S, a company that focuses on pharmaceutical innovations. His work at Pharma-Vinci A/S has allowed him to explore new avenues in drug delivery systems, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Carsten has collaborated with esteemed colleagues such as John E. Faber and Arne M. Pedersen. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Carsten Thordal's contributions to the field of pharmaceuticals, particularly through his innovative patent, highlight his role as a key figure in advancing medical treatments. His work continues to influence the industry and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…